NCT02321007 Study of Placental Function in Healthy and Pathological Pregnancies
| NCT ID | NCT02321007 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Colorado, Denver |
| Condition | Pregnancy |
| Study Type | OBSERVATIONAL |
| Enrollment | 1,250 participants |
| Start Date | 2014-09 |
| Primary Completion | 2031-09 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 1,250 participants in total. It began in 2014-09 with a primary completion date of 2031-09.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The purpose of this study is to establish a tissue and data repository consisting of samples of human placentas, umbilical cord blood, and maternal blood, collected at the time of delivery. Specimens will be used in cellular, molecular, and functional studies to learn more about changes in placental structure and function, which can result in serious pregnancy complications and determine life-long health by programming the fetus for future metabolic and cardiovascular disease.
Eligibility Criteria
Inclusion Criteria: * Healthy women delivering at term * Women with pregnancy complications such as: * pre-term birth, * intrauterine growth restriction, * diabetes, and * obesity. Exclusion Criteria: * Women: * under stress, * experiencing pain of labor. * Pregnancies complicated by other pathologies.
Contact & Investigator
Thomas Jansson, MD, PhD
PRINCIPAL INVESTIGATOR
University of Colorado, Denver
Frequently Asked Questions
Who can join the NCT02321007 clinical trial?
This trial is open to female participants only, aged 18 Years or older, up to 45 Years, studying Pregnancy. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT02321007 currently recruiting?
Yes, NCT02321007 is actively recruiting participants. Contact the research team at anita.kramer@ucdenver.edu for enrollment information.
Where is the NCT02321007 trial being conducted?
This trial is being conducted at Aurora, United States.
Who is sponsoring the NCT02321007 clinical trial?
NCT02321007 is sponsored by University of Colorado, Denver. The principal investigator is Thomas Jansson, MD, PhD at University of Colorado, Denver. The trial plans to enroll 1,250 participants.